{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:33:58Z","timestamp":1791185638143,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.3816\/clc.2009.n.007","type":"journal-article","created":{"date-parts":[[2009,3,16]],"date-time":"2009-03-16T21:12:51Z","timestamp":1237237971000},"page":"47-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["XPG mRNA Expression Levels Modulate Prognosis in Resected Non\u2013Small-Cell Lung Cancer in Conjunction with BRCA1 and ERCC1 Expression"],"prefix":"10.3816","volume":"10","author":[{"given":"Roberta","family":"Bartolucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Javier","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laia","family":"Perez-Roca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imane","family":"Chaib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Puma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Farabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Mendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Roila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuro","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Taron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Rosell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.3816\/CLC.2009.n.007_bib1","first-page":"71","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"10.3816\/CLC.2009.n.007_bib2","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1200\/JCO.2007.13.9030","article-title":"Lung Adjuvant Cisplatin Evaluation (LACE): a pooled analysis of five randomized trials including 4,584 patients","volume":"26","author":"Pignon","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLC.2009.n.007_bib3","series-title":"Oncology: An Evidence-Based Approach","first-page":"545","article-title":"Lung cancer","author":"Choy","year":"2006"},{"key":"10.3816\/CLC.2009.n.007_bib4","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.1099314","article-title":"EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy","volume":"304","author":"Paez","year":"2004","journal-title":"Science"},{"key":"10.3816\/CLC.2009.n.007_bib5","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa060467","article-title":"A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer [published erratum in: N Engl J Med 2007; 356:201-2]","volume":"355","author":"Potti","year":"2006","journal-title":"N Engl J Med"},{"key":"10.3816\/CLC.2009.n.007_bib6","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.1158\/1078-0432.CCR-08-0576","article-title":"Three-gene expression signature predicts survival in early-stage squamous cell carcinoma of the lung","volume":"14","author":"Skrzypski","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.3816\/CLC.2009.n.007_bib7","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1158\/1078-0432.CCR-08-0544","article-title":"A multigene assay is prognostic of survival in patients with early-stage lung adenocarcinoma","volume":"14","author":"Raz","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.3816\/CLC.2009.n.007_bib8","doi-asserted-by":"crossref","first-page":"e1129","DOI":"10.1371\/journal.pone.0001129","article-title":"BRCA1: a novel prognostic factor in resected non-small-cell lung cancer","volume":"2","author":"Rosell","year":"2007","journal-title":"PLoS ONE"},{"key":"10.3816\/CLC.2009.n.007_bib9","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1200\/JCO.2006.09.7915","article-title":"Customizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression: a phase III trial in non-small-cell lung cancer","volume":"25","author":"Cobo","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLC.2009.n.007_bib10","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/carcin\/bgm282","article-title":"Xeroderma pigmentosum genes: functions inside and outside DNA repair","volume":"29","author":"Sugasawa","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.3816\/CLC.2009.n.007_bib11","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1093\/hmg\/ddh260","article-title":"BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer","volume":"13","author":"Taron","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.3816\/CLC.2009.n.007_bib12","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1038\/sj.onc.1206419","article-title":"Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer","volume":"22","author":"Rosell","year":"2003","journal-title":"Oncogene"},{"key":"10.3816\/CLC.2009.n.007_bib13","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1158\/1078-0432.CCR-03-0156","article-title":"Ribonucleotide reductase messenger RNA expression and survival in gemcitabine\/cisplatin-treated advanced non-small cell lung cancer patients","volume":"10","author":"Rosell","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.3816\/CLC.2009.n.007_bib14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1146\/annurev.genet.40.110405.090428","article-title":"Cellular responses to DNA damage: one signal, multiple choices","volume":"40","author":"Su","year":"2006","journal-title":"Annu Rev Genet"},{"key":"10.3816\/CLC.2009.n.007_bib15","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nrc2344","article-title":"Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability","volume":"8","author":"Bristow","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.3816\/CLC.2009.n.007_bib16","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1126\/science.1140735","article-title":"An oncogene-induced DNA damage model for cancer development","volume":"319","author":"Halazonetis","year":"2008","journal-title":"Science"},{"key":"10.3816\/CLC.2009.n.007_bib17","doi-asserted-by":"crossref","first-page":"6884","DOI":"10.1158\/0008-5472.CAN-08-1101","article-title":"BCR\/ABL and other kinases from chronic myeloproliferative disorders stimulate single-strand annealing, an unfaithful DNA double-strand break repair","volume":"68","author":"Cramer","year":"2008","journal-title":"Cancer Res"},{"key":"10.3816\/CLC.2009.n.007_bib18","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/jnci\/djj103","article-title":"Gene expression profiling of primary cutaneous melanoma and clinical outcome","volume":"98","author":"Winnepenninckx","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.3816\/CLC.2009.n.007_bib19","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/sj.onc.1210700","article-title":"High expression of DNA repair pathways is associated with metastasis in melanoma patients","volume":"27","author":"Kauffmann","year":"2008","journal-title":"Oncogene"},{"key":"10.3816\/CLC.2009.n.007_bib20","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.molcel.2007.11.015","article-title":"The DNA damage response: ten years after","volume":"28","author":"Harper","year":"2007","journal-title":"Mol Cell"},{"key":"10.3816\/CLC.2009.n.007_bib21","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.1140321","article-title":"ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage","volume":"316","author":"Matsuoka","year":"2007","journal-title":"Science"},{"key":"10.3816\/CLC.2009.n.007_bib22","first-page":"6221","article-title":"BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis","volume":"63","author":"Quinn","year":"2003","journal-title":"Cancer Res"},{"key":"10.3816\/CLC.2009.n.007_bib23","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.1158\/1078-0432.CCR-07-1083","article-title":"BRCA1 mRNA expression levels predict for overall survival in ovarian cancer after chemotherapy","volume":"13","author":"Quinn","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.3816\/CLC.2009.n.007_bib24","doi-asserted-by":"crossref","first-page":"7713","DOI":"10.1158\/0008-5472.CAN-07-1083","article-title":"The let-7 microRNA represses cell proliferation pathways in human cells","volume":"67","author":"Johnson","year":"2007","journal-title":"Cancer Res"},{"key":"10.3816\/CLC.2009.n.007_bib25","doi-asserted-by":"crossref","first-page":"8065","DOI":"10.1158\/0008-5472.CAN-07-1515","article-title":"Identification of an integrated SV40 T\/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis [published erratum in: Cancer Res 2007; 67:10067]","volume":"67","author":"Deeb","year":"2007","journal-title":"Cancer Res"},{"key":"10.3816\/CLC.2009.n.007_bib26","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJMoa060570","article-title":"DNA repair by ERCC1 in non-smallcell lung cancer and cisplatin-based adjuvant chemotherapy","volume":"355","author":"Olaussen","year":"2006","journal-title":"N Engl J Med"},{"key":"10.3816\/CLC.2009.n.007_bib27","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJMoa065411","article-title":"DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer","volume":"356","author":"Zheng","year":"2007","journal-title":"N Engl J Med"},{"key":"10.3816\/CLC.2009.n.007_bib28","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/1097-0215(20000920)89:5<453::AID-IJC9>3.0.CO;2-E","article-title":"ERCC1 expression as a molecular marker of cisplatin resistance in human cervical tumor cells","volume":"89","author":"Britten","year":"2000","journal-title":"Int J Cancer"},{"key":"10.3816\/CLC.2009.n.007_bib29","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1038\/onc.2008.51","article-title":"Expression of the BRCA1-interacting protein Brip1\/BACH1\/FANCJ is driven by E2F and correlates with human breast cancer malignancy","volume":"27","author":"Eelen","year":"2008","journal-title":"Oncogene"},{"key":"10.3816\/CLC.2009.n.007_bib30","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1126\/science.1139516","article-title":"RAP80 targets BRCA1 to specific ubiquitin structures at DNA damage sites","volume":"316","author":"Sobhian","year":"2007","journal-title":"Science"},{"key":"10.3816\/CLC.2009.n.007_bib31","doi-asserted-by":"crossref","first-page":"5039","DOI":"10.1158\/0008-5472.CAN-05-4194","article-title":"BRCC36 is essential for ionizing radiationinduced BRCA1 phosphorylation and nuclear foci formation","volume":"66","author":"Chen","year":"2006","journal-title":"Cancer Res"},{"key":"10.3816\/CLC.2009.n.007_bib32","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/35024111","article-title":"TFIIH is negatively regulated by cdk8-containing mediator complexes","volume":"407","author":"Akoulitchev","year":"2000","journal-title":"Nature"},{"key":"10.3816\/CLC.2009.n.007_bib33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1097-2765(03)00521-5","article-title":"Ras induces mediator complex exchange on C\/EBP beta","volume":"13","author":"Mo","year":"2004","journal-title":"Mol Cell"},{"key":"10.3816\/CLC.2009.n.007_bib34","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nature07179","article-title":"CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity","volume":"455","author":"Firestein","year":"2008","journal-title":"Nature"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152573041170081X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152573041170081X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:56:19Z","timestamp":1761504979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152573041170081X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S152573041170081X"],"URL":"https:\/\/doi.org\/10.3816\/clc.2009.n.007","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"XPG mRNA Expression Levels Modulate Prognosis in Resected Non\u2013Small-Cell Lung Cancer in Conjunction with BRCA1 and ERCC1 Expression","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3816\/CLC.2009.n.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}